Linea Guida - Agenzia di Sanità Pubblica della Regione Lazio

More documents

Recommendations

Info

112 PROFILASSI DELLA TROMBOEMBOLIA VENOSA POST-CHIRURGICA Leclerc JR, Gent M, Hirsh J et al. 1998, The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty, Arch Intern Med, 158: 873-8. Leizorovicz A 1996, Comparison of the efficacy and safety of low-molecular-weight heparins and unfractionated heparin in the initial treatment of deep venous thrombosis. An updated meta-analysis, Drugs, 52 (suppl 7): 30-7. Lensing AWA, Doris CI, McGrath FP et al. 1997, A comparison of compression ultrasound with color Doppler ultrasound for the diagnosis of symptomless postoperative deep vein thrombosis, Arch Intern Med, 157: 765-8. Levi D, Kupfter Y, Seneviratne C et al. 1998, Computerized order entry sets and intensive education improve the rate of prophylaxis for deep vein thrombophlebitis [abstract], Chest, 114 (suppl): 280S. Levine MN, Gent M, Hirsh J et al. 1996, Ardeparin (lowmolecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism: a randomized trial in patients undergoing knee surgery, Arch Intern Med, 156: 851-6. Leyvraz PF, Bachmann F, Hoek J et al. 1991, Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low-molecular-weight heparin, BMJ, 303: 543-8. Leyvraz PF, Richard J, Bachmann F et al. 1983, Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep vein thrombosis after total hip replacement, N Engl J Med, 309: 954-8. Lindahl TL, Lundahl TH, Nilsson L et al. 1999, APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee: a prospective study, Thromb Haemost, 81: 18-21. Lindberg F, Rasmussen I, Siegbahn A et al. 2000, Coagulation activation after laparoscopic cholecystectomy in spite of thromboembolism prophylaxis, Surg Endosc, 14: 858-61. Lindblad B, Eriksson A, Bergqvist D 1991, Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1968, Br J Surg 78: 849-52. Lotke PA, Palevsky H, Keenan AM et al. 1996, Aspirin and warfarin for thromboembolic disease after total joint arthroplasty, Clin Orthop, 324: 251-8. Lotke PA, Steinberg ME, Ecker ML 1994, Significance of deep venous thrombosis in the lower extremity after total joint arthroplasty, Clin Orthop, 229: 25-30. Lowe GD 1984, Blood rheology and venous thrombosis, Clin Hemorheol, 4: 571-88.
BIBLIOGRAFIA Lowe GD, Campbell AF, Meek DR et al. 1978, Subcutaneous ancrod in prevention of deep vein thrombosis after operation for fractured neck of femur, Lancet, ii: 698-700. Lowe GD, Haverkate F, Thompson SG et al. 1999, Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: the ECAT DVT Study. European Concerted Action on Thrombosis, Thromb Haemost, 81: 879-86. Lowe GD, Osborne DH, McArdle BM et al. 1982, Prediction and selective prophylaxis of venous thrombosis in elective gastrointestinal surgery, Lancet, 1: 409-12. Lumpkin MM 1998, FDA public health advisory, Anaesthesiology, 88: 27A-28A. Lynch AF, Bourne RB, Rorabeck CH et al. 1988, Deep-vein thrombosis and continuous passive motion after total knee arthroplasty, J Bone Joint Surg Am, 70: 11-4. Macdonald RL, Amidei C, Lin G et al. 1999, Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy, J Neurosurg, 45: 245-51. Macklon NS, Greer IA 1996, Venous thromboembolic disease in obstetrics and gynecology: the Scottish experience, Scott Med J, 41: 83-6. Macouillard G, Castagnera L, Claverie JP et al. 1993, Prevention of deep venous thrombosis in spinal surgery: comparison of intermittent sequential pneumatic compression versus low-molecular-weight heparin [abstract], Thromb Haemost, 69: 646. Magnusson M, Eriksson BI, Kalebo P et al. 1996, Is color Doppler ultrasound a sensitive screening method in diagnosing deep vein thrombosis after hip surgery?, Thromb Haemost, 75: 242-5. Mahomed NN, Barrett JA, Latz JN et al. 2003, Rates and outcomes of primary and revision total hip replacement in the United States Medicare population, J Bone Joint Surg Am, 85: 27-32. Marras LC, Geerts WH, Perry JR 2000, The risk of venous thromboembolism is increased throughout the course of maglignant glioma: an evidence-based review, Cancer, 89: 640-6. Marik PE, Andrews L, Maini B 1997, The incidence of deep venous thrombosis in ICU patients, Chest, 111: 661-4. Maxwell RA, Chavarria-Aguilar M, Cockerham WT et al. 2002, Routine prophylactic vena cava filtration is not indicated after acute spinal cord injury, J Trauma, 52: 902-6. McKenna R, Galante J, Bachmann F et al. 1980, Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression, BMJ, 280: 514-7. 113
Page 1 and 2:
LAZIOSANITÀ - AGENZIA DI SANITÀ P
Page 3 and 4:
Indice p. 6 Il Gruppo di Lavoro 9 1
Page 5 and 6:
p. 69 8. Traumi Raccomandazioni 72
Page 7 and 8:
Prof. Raffaele Landolfi Professore
Page 9 and 10:
10 PROFILASSI DELLA TROMBOEMBOLIA V
Page 11 and 12:
Page 13 and 14:
Page 16 and 17:
2. Metodi di sviluppo della Linea G
Page 18 and 19:
- exp heparin, low-molecular-weight
Page 20 and 21:
METODI DI SVILUPPO DELLA LINEA GUID
Page 22 and 23:
- pubblicazioni scientifiche; - pre
Page 24 and 25:
3. I fattori di rischio per la trom
Page 26 and 27:
I FATTORI DI RISCHIO PER LA TROMBOE
Page 28 and 29:
4. Metodi per la profilassi Di segu
Page 30 and 31:
METODI PER LA PROFILASSI to risulta
Page 32 and 33:
METODI PER LA PROFILASSI Raccomanda
Page 34:
Eparine a basso peso molecolare. Le
Page 37 and 38:
Page 39 and 40:
Nome e anno Mismetti 2001 Koch 2001
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 48 and 49:
6. Chirurgia vascolare 6.1. Chirurg
Page 50 and 51:
7. Chirurgia ortopedica e neurochir
Page 52 and 53:
considerati nella LG dell’ACCP, s
Page 54 and 55:
7.1.3. Profilassi farmacologica CHI
Page 56 and 57:
CHIRURGIA ORTOPEDICA E NEUROCHIRURG
Page 58 and 59:
CHIRURGIA ORTOPEDICA E NEUROCHIRURG
Page 60 and 61: CHIRURGIA ORTOPEDICA E NEUROCHIRURG
Page 62 and 63: 7.6. Durata della profilassi CHIRUR
Page 64 and 65: CHIRURGIA ORTOPEDICA E NEUROCHIRURG
Page 66 and 67: dell’ACCP, settima revisione (Gee
Page 68 and 69: 8. Traumi I pazienti politraumatizz
Page 70 and 71: ati di contenzione (Greenfield 1997
Page 72 and 73: TRAUMI degli arti inferiori ed il r
Page 74 and 75: 9. Farmaci antitrombotici ed aneste
Page 76 and 77: FARMACI ANTITROMBOTICI ED ANESTESIA
Page 78 and 79: 10. Terapia intensiva I pazienti ch
Page 80 and 81: 11. Pazienti con malattia oncologic
Page 82: Sintesi per i pazienti I pazienti c
Page 86 and 87: A. Indagini diagnostiche di screeni
Page 88 and 89: B. Elenco delle principali Linee Gu
Page 90 and 91: 92 PROFILASSI DELLA TROMBOEMBOLIA V
Page 98 and 99: 100 PROFILASSI DELLA TROMBOEMBOLIA
show all

Linea Guida - Agenzia di Sanità Pubblica della Regione Lazio

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?